M Konishi Selected Research

M Konishi Research Topics

Disease

6	Neoplasms (Cancer) 12/2001 - 02/2000
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2001 - 01/2000
3	Neoplasm Metastasis (Metastasis) 12/2006 - 01/2001
2	Chronic Hepatitis C 07/2006 - 03/2006
2	Body Weight (Weight, Body) 12/2001 - 06/2000
2	Cholangiocarcinoma 05/2000 - 01/2000
2	Carcinoma (Carcinomatosis) 05/2000 - 01/2000
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2018
1	Residual Neoplasm 01/2018
1	Exfoliative Dermatitis (Erythroderma) 03/2015
1	Drug Eruptions (Drug Eruption) 03/2015
1	Hypoxia (Hypoxemia) 03/2010
1	Type 2 Diabetes Mellitus (MODY) 03/2010
1	Osteoporosis 11/2009
1	Hepatocellular Carcinoma (Hepatoma) 10/2007
1	Liver Diseases (Liver Disease) 07/2006
1	Virus Diseases (Viral Diseases) 07/2006
1	Obesity 11/2003
1	Cachexia 12/2001
1	Diffuse panbronchiolitis 10/2001
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2001
1	Chronic Bronchitis 10/2001
1	Bronchiectasis 10/2001
1	Thrombosis (Thrombus) 09/2001
1	Orthostatic Hypotension (Postural Hypotension) 05/2001
1	Pancreatic Ductal Carcinoma 03/2001
1	Inflammation (Inflammations) 03/2001
1	Adenocarcinoma 01/2001
1	Neutropenia 01/2001
1	Stomach Neoplasms (Stomach Cancer) 01/2001
1	Amyloid Plaque 11/2000
1	Hereditary Corneal Dystrophies 11/2000
1	Hemorrhage 07/2000
1	Stomach Ulcer (Gastric Ulcer) 07/2000
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2000
1	Endometrial Neoplasms (Endometrial Cancer) 05/2000
1	Margins of Excision 05/2000
1	Carotid Artery Diseases 05/2000
1	Lymphatic Metastasis 05/2000
1	Hypertension (High Blood Pressure) 05/2000
1	Polyps 02/2000
1	Lysinuric Protein Intolerance 01/2000

Drug/Important Bio-Agent (IBA)

4	Clarithromycin (Biaxin)FDA LinkGeneric 12/2001 - 01/2000
2	Ribavirin (Virazole)FDA LinkGeneric 07/2006 - 03/2006
2	InterferonsIBA 07/2006 - 03/2006
1	Gemcitabine FDA Link 01/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2015
1	Insulin (Novolin)FDA Link 03/2010
1	Biomarkers (Surrogate Marker)IBA 03/2010
1	Glucose (Dextrose)FDA LinkGeneric 03/2010
1	Oxygen (Dioxygen)IBA 03/2010
1	Risedronic Acid (Actonel)FDA LinkGeneric 11/2009
1	Collagen Type I (Type I Collagen)IBA 11/2009
1	BezafibrateIBA 07/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2006
1	low density lipoprotein inhibitorIBA 07/2006
1	RNA (Ribonucleic Acid)IBA 07/2006
1	Antiviral Agents (Antivirals)IBA 03/2006
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2006
1	LeptinIBA 11/2003
1	Leptin ReceptorsIBA 11/2003
1	Interleukin-6 (Interleukin 6)IBA 12/2001
1	Hemoglobins (Hemoglobin)IBA 12/2001
1	Cholinesterases (Cholinesterase)IBA 12/2001
1	Proteins (Proteins, Gene)FDA Link 12/2001
1	AlbuminsIBA 12/2001
1	CytokinesIBA 12/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2001
1	MacrolidesIBA 10/2001
1	hydroxide ionIBA 05/2001
1	Tuberculin (PPD)IBA 03/2001
1	LipopolysaccharidesIBA 03/2001
1	Lewis Blood Group AntigensIBA 01/2001
1	Fluorouracil (Carac)FDA LinkGeneric 01/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2001
1	Cell Adhesion MoleculesIBA 01/2001
1	Methotrexate (Mexate)FDA LinkGeneric 01/2001
1	Sialyl Lewis X AntigenIBA 01/2001
1	Coloring Agents (Dyes)IBA 11/2000
1	betaIG-H3 protein (keratoepithelin)IBA 11/2000
1	Adenosine Triphosphatases (ATPase)IBA 06/2000
1	HDL CholesterolIBA 05/2000
1	Cisplatin (Platino)FDA LinkGeneric 05/2000
1	CholesterolIBA 05/2000
1	Blood Glucose (Blood Sugar)IBA 05/2000
1	Biological ProductsIBA 05/2000
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2000
1	Messenger RNA (mRNA)IBA 02/2000
1	AgarIBA 02/2000
1	Retinal Pigments (Pigments, Visual)IBA 02/2000
1	Diamino Amino AcidsIBA 01/2000

Therapy/Procedure

9	Therapeutics 01/2018 - 05/2000
4	Hepatectomy 10/2007 - 01/2000
3	Drug Therapy (Chemotherapy) 01/2018 - 01/2001
2	Radiotherapy 12/2001 - 07/2000
1	Adjuvant Chemotherapy 01/2018
1	Aftercare (After-Treatment) 11/2009
1	Neoadjuvant Therapy 01/2001
1	Lymph Node Excision (Lymph Node Dissection) 05/2000
1	Pancreatectomy 01/2000